Date:    March, 7, 2015

Venue: Prague, Czech Republic, Hotel Boscolo

Time:    8:30 – 13:00 hrs

International NIPT Workshop – Clinical Considerations and Future Directions.

March 7th        8:30 AM

 8:30       Breakfast hosted by Illumina

9:00        General Introductions – Pavel Calda, MD PhD, Professor, Head of the Centre of Fetal Medicine and Ultrasound Unit Charles University in Prague

9:15       NIPT History/Background – Pavel Calda, MD PhD

10:00     Technological Comparison / Current Testing Overview – Christin Coffeen, Illumina Genetic Counselor

10:30     Coffee Break

10:45     NIPT in average risk population – Gyula Richárd Nagy MD, PhD, Director, Intelligenetic ltd

11:15     Evolution of NIPT, what’s next (test menu and logistics) – Nargol Faraveshi, Sr. Manager for Product Development for NIPT at Illumina

11:45 – 1pm

Panel Discussion with Q&A – open discussion for the audience to ask questions of the Advisory Session Members

Moderator: Dr. Sucheta Bhatt, Director, Genetics, Illumina

  • Clinical implementations considerations: physician perspective
    • NIPT in high risk women
    • NIPT in average risk women: how should NIPT be used in general OB-GYN population?
    • NIPT for microdeletions: how to integrate into clinical practice?
    • Lab preference: local or acceptable to work with labs overseas? VeriSeqNIPT Solution
    • Implications of failed NIPT results and TAT
  • Clinical implementations considerations : regional healthcare perspective
  • Regional patient education
  • Future directions of cell-free nucleic acid technology

1:00       Lunch

Translation service will be provided

Workshop languages are English and Czech, presentations will be translated sibultaneously to both languages.

Faculty:  prof. Pavel Calda, Dr. Gyula R.Nagy, Christin Coffeen, Dr. Sucheta Bhatt

sponsored by Illumina

Drahomíra Kovaříková
P.O.Box 33, 148 00 Praha 4
GSM: +420 603887297